Search Count: 10
 |
Amidobenzimidazole (Abzi) Sting Agonists
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.91 Å Release Date: 2018-11-07 Classification: immune system/agonist Ligands: CA, HGJ |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2018-11-07
Ligands: CA, HGJ
 |
Human Sting With Diabzi Agonist 15
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.97 Å Release Date: 2023-07-26 Classification: IMMUNE SYSTEM/AGONIST Ligands: WWU |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2023-07-26
Ligands: WWU
 |
Human Sting With Agonist Xmt-1616
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.72 Å Release Date: 2023-07-26 Classification: IMMUNE SYSTEM/AGONIST Ligands: WX8 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2023-07-26
Ligands: WX8
 |
Linked Amidobenzimidazole Sting Agonist
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.45 Å Release Date: 2018-11-07 Classification: immune system/agonist Ligands: HG4, CA |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2018-11-07
Ligands: HG4, CA
 |
Crystal Structure Of The Human Tlr2-Diprovocim Complex
Organism: Homo sapiens, Eptatretus stoutii
Method: X-RAY DIFFRACTION Resolution:2.35 Å Release Date: 2019-04-17 Classification: IMMUNE SYSTEM/AGONIST Ligands: KQD, NAG |
Organism: Homo sapiens, Eptatretus stoutii
Method: X-RAY DIFFRACTION
Release Date: 2019-04-17
Ligands: KQD, NAG
 |
Crystal Structure Of The Murine Class I Major Histocompatibility Complex H-2Db In Complex With The Lcmv-Derived Gp33 Altered Peptide Ligand (A2G, V3P, Y4S)
Organism: Mus musculus, Lymphocytic choriomeningitis virus
Method: X-RAY DIFFRACTION Resolution:2.15 Å Release Date: 2012-08-08 Classification: Immune system/agonist |
Organism: Mus musculus, Lymphocytic choriomeningitis virus
Method: X-RAY DIFFRACTION
Release Date: 2012-08-08
 |
Crystal Structure Of The Murine Class I Major Histocompatibility Complex H-2Db In Complex With The Lcmv-Derived Gp33 Altered Peptide Ligand (V3P, Y4S)
Organism: Mus musculus, Lymphocytic choriomeningitis virus
Method: X-RAY DIFFRACTION Resolution:2.30 Å Release Date: 2012-08-08 Classification: Immune system/agonist |
Organism: Mus musculus, Lymphocytic choriomeningitis virus
Method: X-RAY DIFFRACTION
Release Date: 2012-08-08
 |
Crystal Structure Of The Murine Class I Major Histocompatibility Complex H-2Db In Complex The With Lcmv-Derived Gp33 Altered Peptide Ligand (V3P,Y4A)
Organism: Mus musculus, Lymphocytic choriomeningitis virus
Method: X-RAY DIFFRACTION Resolution:2.49 Å Release Date: 2012-08-08 Classification: Immune system/agonist Ligands: SO4, GOL |
Organism: Mus musculus, Lymphocytic choriomeningitis virus
Method: X-RAY DIFFRACTION
Release Date: 2012-08-08
Ligands: SO4, GOL
 |
Crystal Structure Of The Murine Class I Major Histocompatibility Complex H-2Db In Complex With The Lcmv-Derived Gp33 Altered Peptide Ligand (A2G,V3P,Y4A)
Organism: Mus musculus, Lymphocytic choriomeningitis virus
Method: X-RAY DIFFRACTION Resolution:2.10 Å Release Date: 2012-08-08 Classification: Immune system/agonist Ligands: SO4, GOL |
Organism: Mus musculus, Lymphocytic choriomeningitis virus
Method: X-RAY DIFFRACTION
Release Date: 2012-08-08
Ligands: SO4, GOL
 |
Crystal Structure Of The Murine Class I Major Histocompatibility Complex H-2Db In Complex With The Lcmv-Derived Gp33 Altered Peptide Ligand (V3P, Y4F)
Organism: Mus musculus, Lymphocytic choriomeningitis virus
Method: X-RAY DIFFRACTION Resolution:2.50 Å Release Date: 2012-08-08 Classification: Immune system/agonist |
Organism: Mus musculus, Lymphocytic choriomeningitis virus
Method: X-RAY DIFFRACTION
Release Date: 2012-08-08